NASDAQ: CURRCurrenc Group Inc Stock
$1.39-0.01 (-0.71%)
Updated Dec 11, 2024
CURR Price
$1.39
Fair Value Price
N/A
Market Cap
$64.67M
52 Week Low
$1.36
52 Week High
$13.59
P/E
-2.17x
P/B
-1.38x
P/S
1.08x
PEG
N/A
Dividend Yield
N/A
Revenue
$88.63M
Earnings
-$29.52M
Gross Margin
32.4%
Operating Margin
-14.76%
Profit Margin
-33.3%
Debt to Equity
-2.93
Operating Cash Flow
-$27M
Beta
0.06
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
CURR Overview
InFinT Acquisition Corporation is a "blank check" company formed to effect mergers, share exchanges, asset acquisitions, share purchases, reorganizations, or similar business combinations. It targets the fintech sector in North America, Asia, Latin America, Europe, and Israel. InFinT Acquisition was incorporated in 2021 and is headquartered in New York, NY.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine CURR's potential to beat the market
FStrong Sell
- Stocks with a Zen Rating of Strong Sell (F) had an average loss of -8.02% per year. Learn More
Zen Rating Component Grades
D
Value
D
Growth
D
Momentum
C
Sentiment
F
Safety
F
Financials
C
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: App
Industry Rating
B
CURR
Ranked#202 of 206
Ranked#202 of 206
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $3.85 | A | |
| $3.98 | A | |
| $21.04 | A |
Be the first to know about important CURR news, forecast changes, insider trades & much more!
CURR News
Overview
Due Diligence Score
–
Industry Average (28)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CURR scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CURR is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CURR is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
CURR's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more CURR due diligence checks available for Premium users.
Valuation
CURR price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-2.17x
Industry
36.39x
Market
29.76x
CURR price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-1.38x
Industry
8.17x
CURR's financial health
Profit margin
Revenue
$11.3M
Net Income
-$5.0M
Profit Margin
-44.1%
CURR's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
CURR's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$115.0M
Liabilities
$137.7M
Debt to equity
-2.93
CURR's short-term liabilities ($136.66M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CURR's short-term assets ($82.53M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CURR's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CURR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$9.6M
Investing
-$166.1k
Financing
$1.9M
CURR's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
CURR vs App Stocks
Currenc Group Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.